Literature DB >> 33445604

Psychophysical Evaluation of the Olfactory Function: European Multicenter Study on 774 COVID-19 Patients.

Luigi Angelo Vaira1,2,3, Jerome R Lechien1,4,5,6, Mohamad Khalife1,7, Marzia Petrocelli8, Stephane Hans1,5, Lea Distinguin1,5, Giovanni Salzano9, Marco Cucurullo10, Piero Doneddu2, Francesco Antonio Salzano11, Federico Biglioli10, Fabrice Journe4, Andrea Fausto Piana3,12, Giacomo De Riu1,2,3, Sven Saussez1,4,6.   

Abstract

BACKGROUND: The objective evaluation of the olfactory function of coronavirus disease 2019 patients is difficult because of logistical and operator-safety problems. For this reason, in the literature, the data obtained from psychophysical tests are few and based on small case series.
METHODS: A multicenter, cohort study conducted in seven European hospitals between March 22 and August 20, 2020. The Sniffin-Sticks test and the Connecticut Chemosensory Clinical Research Center orthonasal olfaction test were used to objectively evaluate the olfactory function.
RESULTS: This study included 774 patients, of these 481 (62.1%) presented olfactory dysfunction (OD): 280 were hyposmic and 201 were anosmic. There was a significant difference between self-reported anosmia/hyposmia and psychophysical test results (p = 0.006). Patients with gastroesophageal disorders reported a significantly higher probability of presenting hyposmia (OR 1.86; p = 0.015) and anosmia (OR 2.425; p < 0.001). Fever, chest pain, and phlegm significantly increased the likelihood of having hyposmia but not anosmia or an olfactory disturbance. In contrast, patients with dyspnea, dysphonia, and severe-to-critical COVID-19 were significantly more likely to have no anosmia, while these symptoms had no effect on the risk of developing hyposmia or an OD.
CONCLUSIONS: Psychophysical assessment represents a significantly more accurate assessment tool for olfactory function than patient self-reported clinical outcomes. Olfactory disturbances appear to be largely independent from the epidemiological and clinical characteristics of the patients. The non-association with rhinitis symptoms and the high prevalence as a presenting symptom make olfactory disturbances an important symptom in the differential diagnosis between COVID-19 and common flu.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; anosmia; hyposmia; olfaction; olfactory dysfunction; parosmia; smell

Year:  2021        PMID: 33445604      PMCID: PMC7827350          DOI: 10.3390/pathogens10010062

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  54 in total

1.  Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection.

Authors:  Giacomo Spinato; Cristoforo Fabbris; Jerry Polesel; Diego Cazzador; Daniele Borsetto; Claire Hopkins; Paolo Boscolo-Rizzo
Journal:  JAMA       Date:  2020-05-26       Impact factor: 56.272

2.  Six month follow-up of self-reported loss of smell during the COVID-19 pandemic.

Authors:  C Hopkins; P Surda; L A Vaira; J R Lechien; M Safarian; S Saussez; N Kumar
Journal:  Rhinology       Date:  2020-12-15       Impact factor: 3.681

3.  More Than Smell-COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis.

Authors:  Valentina Parma; Kathrin Ohla; Maria G Veldhuizen; Masha Y Niv; Christine E Kelly; Alyssa J Bakke; Keiland W Cooper; Cédric Bouysset; Nicola Pirastu; Michele Dibattista; Rishemjit Kaur; Marco Tullio Liuzza; Marta Y Pepino; Veronika Schöpf; Veronica Pereda-Loth; Shannon B Olsson; Richard C Gerkin; Paloma Rohlfs Domínguez; Javier Albayay; Michael C Farruggia; Surabhi Bhutani; Alexander W Fjaeldstad; Ritesh Kumar; Anna Menini; Moustafa Bensafi; Mari Sandell; Iordanis Konstantinidis; Antonella Di Pizio; Federica Genovese; Lina Öztürk; Thierry Thomas-Danguin; Johannes Frasnelli; Sanne Boesveldt; Özlem Saatci; Luis R Saraiva; Cailu Lin; Jérôme Golebiowski; Liang-Dar Hwang; Mehmet Hakan Ozdener; Maria Dolors Guàrdia; Christophe Laudamiel; Marina Ritchie; Jan Havlícek; Denis Pierron; Eugeni Roura; Marta Navarro; Alissa A Nolden; Juyun Lim; Katherine L Whitcroft; Lauren R Colquitt; Camille Ferdenzi; Evelyn V Brindha; Aytug Altundag; Alberto Macchi; Alexia Nunez-Parra; Zara M Patel; Sébastien Fiorucci; Carl M Philpott; Barry C Smith; Johan N Lundström; Carla Mucignat; Jane K Parker; Mirjam van den Brink; Michael Schmuker; Florian Ph S Fischmeister; Thomas Heinbockel; Vonnie D C Shields; Farhoud Faraji; Enrique Santamaría; William E A Fredborg; Gabriella Morini; Jonas K Olofsson; Maryam Jalessi; Noam Karni; Anna D'Errico; Rafieh Alizadeh; Robert Pellegrino; Pablo Meyer; Caroline Huart; Ben Chen; Graciela M Soler; Mohammed K Alwashahi; Antje Welge-Lüssen; Jessica Freiherr; Jasper H B de Groot; Hadar Klein; Masako Okamoto; Preet Bano Singh; Julien W Hsieh; Danielle R Reed; Thomas Hummel; Steven D Munger; John E Hayes
Journal:  Chem Senses       Date:  2020-10-09       Impact factor: 3.160

4.  Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients.

Authors:  Yonghyun Lee; Pokkee Min; Seonggu Lee; Shin Woo Kim
Journal:  J Korean Med Sci       Date:  2020-05-11       Impact factor: 2.153

5.  Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases.

Authors:  Luigi Angelo Vaira; Giovanna Deiana; Alessandro Giuseppe Fois; Pietro Pirina; Giordano Madeddu; Andrea De Vito; Sergio Babudieri; Marzia Petrocelli; Antonello Serra; Francesco Bussu; Enrica Ligas; Giovanni Salzano; Giacomo De Riu
Journal:  Head Neck       Date:  2020-04-29       Impact factor: 3.147

6.  Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study.

Authors:  Luigi Angelo Vaira; Claire Hopkins; Giovanni Salzano; Marzia Petrocelli; Andrea Melis; Marco Cucurullo; Mario Ferrari; Laura Gagliardini; Carlotta Pipolo; Giovanna Deiana; Vito Fiore; Andrea De Vito; Nicola Turra; Sara Canu; Angelantonio Maglio; Antonello Serra; Francesco Bussu; Giordano Madeddu; Sergio Babudieri; Alessandro Giuseppe Fois; Pietro Pirina; Francesco A Salzano; Pierluigi De Riu; Federico Biglioli; Giacomo De Riu
Journal:  Head Neck       Date:  2020-05-21       Impact factor: 3.821

7.  Neurological features in SARS-CoV-2-infected patients with smell and taste disorder.

Authors:  Antoniangela Cocco; Paolo Amami; Antonio Desai; Antonio Voza; Fabio Ferreli; Alberto Albanese
Journal:  J Neurol       Date:  2020-08-07       Impact factor: 4.849

8.  ACE2 & TMPRSS2 Expressions in Head & Neck Tissues: A Systematic Review.

Authors:  Jerome R Lechien; Thomas Radulesco; Justin Michel; Sven Saussez; Christian Calvo-Henriquez; Carlos M Chiesa-Estomba; Stéphane Hans; Maria R Barillari; Giovanni Cammaroto; Géraldine Descamps; Julien Hsieh; Luigi Vaira; Giacomo De Riu; Leigh Sowerby; Isabelle Gengler
Journal:  Head Neck Pathol       Date:  2020-08-20

9.  Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia.

Authors:  L A Vaira; C Hopkins; A Sandison; A Manca; N Machouchas; D Turilli; J R Lechien; M R Barillari; G Salzano; A Cossu; S Saussez; G De Riu
Journal:  J Laryngol Otol       Date:  2020-11-16       Impact factor: 1.469

10.  Smell and taste alterations in COVID-19: a cross-sectional analysis of different cohorts.

Authors:  Alberto Paderno; Alberto Schreiber; Alberto Grammatica; Elena Raffetti; Michele Tomasoni; Tommaso Gualtieri; Stefano Taboni; Silvia Zorzi; Davide Lombardi; Alberto Deganello; Luca Oscar Redaelli De Zinis; Roberto Maroldi; Davide Mattavelli
Journal:  Int Forum Allergy Rhinol       Date:  2020-06-25       Impact factor: 5.426

View more
  13 in total

1.  Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study.

Authors:  Luigi Angelo Vaira; Andrea De Vito; Claire Hopkins; Giacomo De Riu; Giovanna Deiana; Chiara Pes; Federica Giovanditto; Vito Fiore; Jerome R Lechien; Serge-Daniel Le Bon; Sven Saussez; Giordano Madeddu; Sergio Babudieri; Antonio Pazzola; Franco Bandiera; Alessandro Giuseppe Fois; Andrea Fausto Piana
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-05-13       Impact factor: 2.503

2.  Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb.

Authors:  Mona Khan; Seung-Jun Yoo; Marnick Clijsters; Wout Backaert; Arno Vanstapel; Kato Speleman; Charlotte Lietaer; Sumin Choi; Tyler D Hether; Lukas Marcelis; Andrew Nam; Liuliu Pan; Jason W Reeves; Pauline Van Bulck; Hai Zhou; Marc Bourgeois; Yves Debaveye; Paul De Munter; Jan Gunst; Mark Jorissen; Katrien Lagrou; Natalie Lorent; Arne Neyrinck; Marijke Peetermans; Dietmar Rudolf Thal; Christophe Vandenbriele; Joost Wauters; Peter Mombaerts; Laura Van Gerven
Journal:  Cell       Date:  2021-11-03       Impact factor: 41.582

3.  The Effects of Persistent Olfactory and Gustatory Dysfunctions on Quality of Life in Long-COVID-19 Patients.

Authors:  Luigi Angelo Vaira; Claudia Gessa; Giovanna Deiana; Giovanni Salzano; Fabio Maglitto; Jerome R Lechien; Sven Saussez; Pasquale Piombino; Andrea Biglio; Federico Biglioli; Paolo Boscolo-Rizzo; Claire Hopkins; Valentina Parma; Giacomo De Riu
Journal:  Life (Basel)       Date:  2022-01-19

4.  Coronavirus disease 2019 (COVID-19)-related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Omicron variant.

Authors:  Paolo Boscolo-Rizzo; Giancarlo Tirelli; Pierluigi Meloni; Claire Hopkins; Giordano Madeddu; Andrea De Vito; Nicoletta Gardenal; Romina Valentinotti; Margherita Tofanelli; Daniele Borsetto; Jerome R Lechien; Jerry Polesel; Giacomo De Riu; Luigi Angelo Vaira
Journal:  Int Forum Allergy Rhinol       Date:  2022-03-24       Impact factor: 5.426

5.  New Onset of Smell and Taste Loss Are Common Findings Also in Patients With Symptomatic COVID-19 After Complete Vaccination.

Authors:  Luigi A Vaira; Andrea De Vito; Jerome R Lechien; Carlos M Chiesa-Estomba; Miguel Mayo-Yàñez; Christian Calvo-Henrìquez; Sven Saussez; Giordano Madeddu; Sergio Babudieri; Paolo Boscolo-Rizzo; Claire Hopkins; Giacomo De Riu
Journal:  Laryngoscope       Date:  2021-11-26       Impact factor: 3.325

6.  Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study.

Authors:  Sven Saussez; Luigi Angelo Vaira; Carlos M Chiesa-Estomba; Serge-D Le Bon; Mihaela Horoi; Giovanna Deiana; Marzia Petrocelli; Philippe Boelpaep; Giovanni Salzano; Mohamad Khalife; Stephane Hans; Giacomo De Riu; Claire Hopkins; Jerome R Lechien
Journal:  Pathogens       Date:  2021-06-04

Review 7.  Olfactory Dysfunction in Patients With Coronavirus Disease 2019: A Review.

Authors:  Guoli Wei; Jialin Gu; Zhancheng Gu; Cheng Du; Xiaofei Huang; Haiyan Xing; Lingchang Li; Aiping Zhang; Xingxing Hu; Jiege Huo
Journal:  Front Neurol       Date:  2022-01-18       Impact factor: 4.003

8.  Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction.

Authors:  Sven Saussez; Shilpee Sharma; Anaïs Thiriard; Véronique Olislagers; Inès Vu Duc; Serge-D Le Bon; Mohamad Khalife; Stephane Hans; Giacomo De Riu; Claire Hopkins; Jerome R Lechien; Luigi A Vaira; Arnaud Marchant
Journal:  Eur J Neurol       Date:  2021-07-09       Impact factor: 6.288

9.  Analysis of the correlations between the severity of lung involvement and olfactory psychophysical scores in coronavirus disease 2019 (COVID-19) patients.

Authors:  Antonio Matteo Amadu; Luigi Angelo Vaira; Jerome R Lechien; Mariano Scaglione; Luca Saba; Maria Luisa Lampus; Stefano Giorgio Profili; Serge-Daniel Le Bon; Giovanni Salzano; Fabio Maglitto; Sven Saussez; Paolo Boscolo-Rizzo; Claire Hopkins; Giacomo De Riu
Journal:  Int Forum Allergy Rhinol       Date:  2021-07-22       Impact factor: 5.426

10.  Assessment of olfactory and gustatory functions in COVID-19 patients

Authors:  Muammer Melih Şahin; Eray Uzunoğlu; Mücahit Yalçin; Gökçen Cesur; Mehmet Yildiz; Pinar Aysert Yildiz; Hasan Selçuk Özger; Süleyman Cebeci; Recep Karamert; Mehmet Düzlü; Hakan Tutar; Murat Dizbay; Alper Ceylan
Journal:  Turk J Med Sci       Date:  2021-10-21       Impact factor: 0.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.